EP0723584A4 - Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus - Google Patents

Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus

Info

Publication number
EP0723584A4
EP0723584A4 EP94929265A EP94929265A EP0723584A4 EP 0723584 A4 EP0723584 A4 EP 0723584A4 EP 94929265 A EP94929265 A EP 94929265A EP 94929265 A EP94929265 A EP 94929265A EP 0723584 A4 EP0723584 A4 EP 0723584A4
Authority
EP
European Patent Office
Prior art keywords
infectious laryngotracheitis
laryngotracheitis virus
recombinant infectious
recombinant
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94929265A
Other languages
German (de)
English (en)
Other versions
EP0723584A1 (fr
Inventor
Martha A Wild
Mark D Cochran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntro Corp
Original Assignee
Syntro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntro Corp filed Critical Syntro Corp
Publication of EP0723584A1 publication Critical patent/EP0723584A1/fr
Publication of EP0723584A4 publication Critical patent/EP0723584A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP94929265A 1993-09-24 1994-09-16 Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus Withdrawn EP0723584A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12659793A 1993-09-24 1993-09-24
US126597 1993-09-24
PCT/US1994/010628 WO1995008622A1 (fr) 1993-09-24 1994-09-16 Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus

Publications (2)

Publication Number Publication Date
EP0723584A1 EP0723584A1 (fr) 1996-07-31
EP0723584A4 true EP0723584A4 (fr) 2000-12-20

Family

ID=22425710

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94929265A Withdrawn EP0723584A4 (fr) 1993-09-24 1994-09-16 Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus

Country Status (5)

Country Link
EP (1) EP0723584A4 (fr)
JP (1) JPH09505726A (fr)
AU (1) AU7838694A (fr)
CA (1) CA2172387A1 (fr)
WO (1) WO1995008622A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2946395A (en) * 1994-06-30 1996-01-25 Board of Regents of the University of Illinois, The Recombinant infectious laryngotracheitis virus and vaccine
EP0822980A4 (fr) * 1995-03-23 2000-04-26 Syntro Corp Virus de la laryngotracheite infectieuse recombine et ses utilisations
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6180671B1 (en) 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
AU2003239589A1 (en) 2002-05-24 2003-12-12 Schering-Plough Ltd. Eta-1 gene and methods for use
BR112013002525A2 (pt) * 2010-08-02 2016-05-31 Univ Georgia vírus da laringotraqueíte infecciosa (iltv) modificado e usos do mesmo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327437A (ja) * 1986-07-17 1988-02-05 Chemo Sero Therapeut Res Inst 鶏伝染病生ワクチン
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
GB2220941B (en) * 1988-06-24 1991-09-11 Nat Res Dev Fowlpox virus non-essential regions
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
WO1992003554A1 (fr) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Vaccin contre le virus de la laryngotracheite infectieuse
US5279965A (en) * 1991-04-05 1994-01-18 Keeler Jr Calvin L Recombinant infectious laryngotracheitis virus

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JOHNSON M A ET AL: "Gallid herpesvirus 1 (infectious laryngotracheitis virus ): cloning and physical maps of the SA - 2 strain.", ARCHIVES OF VIROLOGY, (1991) 119 (3-4) 181-98., XP000942447 *
KONGSUWAN K ET AL: "Use of lambda gt11 and monoclonal antibodies to map the gene for the 60,000 dalton glycoprotein of infectious laryngotracheitis virus.", VIRUS GENES, (1993 SEP) 7 (3) 297-303., XP000942464 *
SCHNITZLEIN WILLIAM M ET AL: "Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus.", VIROLOGY, vol. 209, no. 2, 1995, pages 304 - 314, XP002149725, ISSN: 0042-6822 *
See also references of WO9508622A1 *
WILD M A ET AL: "A GENOMIC MAP OF INFECTIOUS LARYNGOTRACHEITIS VIRUS AND THE SEQUENCE AND ORGANIZATION OF GENES PRESENT IN THE UNIQUE SHORT AND FLANKING REGIONS", VIRUS GENES,US,KLUWER ACADEMIC PUBLISHERS, BOSTON, vol. 12, no. 2, 1996, pages 107 - 116, XP000645840, ISSN: 0920-8569 *

Also Published As

Publication number Publication date
EP0723584A1 (fr) 1996-07-31
JPH09505726A (ja) 1997-06-10
AU7838694A (en) 1995-04-10
WO1995008622A1 (fr) 1995-03-30
CA2172387A1 (fr) 1995-03-30

Similar Documents

Publication Publication Date Title
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
SG55281A1 (en) Alkylphenylbisacylphosphine oxides and photoiniator mixtures
EP0708658A4 (fr) Vaccin contenant un cytomegalovirus de recombinaison
AU3824595A (en) Recombinant negative strand RNA virus expression systems and vaccines
IL127701A0 (en) Hiv envelope polypeptides and vaccine
EP0644931A4 (fr) Virus de l'herpes des gallinaces type 2 recombine et ses utilisations.
AU3119895A (en) Recombinant virus vectors
EP0973924A4 (fr) Virus chimeres de recombinaison et leurs utilisations
EP0696204A4 (fr) Virus recombinants de la diphterie des volailles et utilisations
EP0747482A3 (fr) Protéines récombinantes de virus de l'hépatite GB et leur utilisations
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
AU5679394A (en) Hepatitis b virus vaccines
EP0723584A4 (fr) Virus de recombinaison de la laryngotracheite infectieuse et utilisations desdits virus
EP0710120A4 (fr) Suipoxvirus recombine
HUP0003327A3 (en) Grapevine leafroll virus (type 2) proteins and their uses
EP0832197A4 (fr) Virus de variole aviaire recombines et leurs utilisations
GB9304239D0 (en) Viral particles
EP1113777A4 (fr) Nouveaux peptides du virus de l'hepatite c et utilisations de ceux-ci
EP0598759A4 (fr) Virus recombinant de la rhino-tracheite infectieuse des bovins.
AU2946395A (en) Recombinant infectious laryngotracheitis virus and vaccine
EP0745133A4 (fr) Virus recombine de la rhinotracheite infectieuse bovine s-ibr-052 et ses utilisations
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
PL317200A1 (en) Msrv-1 virus and patogenous and/or infectious agent msrv-2 associated with rheumatoid arthritis
AU8184898A (en) Recombinant infectious laryngotracheitis virus and uses thereof
EP0692537A3 (fr) ADN récombinante codant pour gibberellin et son utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960423

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20001107

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010102